Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Apr;40(1):36–41.

Trypanosoma cruzi: immunological consequences of parasite modification of host cells.

R Ribeiro Dos Santos, L Hudson
PMCID: PMC1536950  PMID: 6771080

Abstract

Parasite antigens released from Trypanosoma cruzi-infected cells were adsorbed to infected and uninfected mammalian cells thus rendering them susceptible to immune lysis by antibody and cell-mediated immunity directed against the parasite. BALB/c mice infected with T. cruzi for 15 days developed cytotoxic T lymphocytes specific for parasite antigens. At 60 days post infection, however, the mice developed an additional population of cytotoxic T lymphocytes that were able to kill normal syngeneic muscle or neuronederived cell lines in vitro. These '60-day" T lymphocytes did not kill HeLa cells unless they were coated with T. cruzi antigens suggesting that the population of atuoaggressive T lymphocytes was not an artefact due to an increase in natural killer cells.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cossio P. M., Laguens R. P., Diez C., Szarfman A., Segal A., Arana R. M. Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation. 1974 Dec;50(6):1252–1259. doi: 10.1161/01.cir.50.6.1252. [DOI] [PubMed] [Google Scholar]
  2. Fudenberg H. H. Molecular theology, immunophilosophy, and autoimmune disease. Scand J Immunol. 1978;7(5):351–355. doi: 10.1111/j.1365-3083.1978.tb00464.x. [DOI] [PubMed] [Google Scholar]
  3. Gravely S. M., Kreier J. P. Adoptive transfer of immunity to Plasmodium berghei with immune T and B lymphocytes. Infect Immun. 1976 Jul;14(1):184–190. doi: 10.1128/iai.14.1.184-190.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kuhn R. E., Murnane J. E. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro. Exp Parasitol. 1977 Feb;41(1):66–73. doi: 10.1016/0014-4894(77)90130-8. [DOI] [PubMed] [Google Scholar]
  5. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol. 1968;6:63–116. doi: 10.1016/s0065-308x(08)60472-8. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Santos-Buch C. A., Teixeira A. R. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J Exp Med. 1974 Jul 1;140(1):38–53. doi: 10.1084/jem.140.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Teixeira A. R., Santos-Buch C. A. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens. Immunology. 1975 Mar;28(3):401–410. [PMC free article] [PubMed] [Google Scholar]
  9. Teixeira A. R., Teixeira G., Macêdo V., Prata A. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease. Am J Trop Med Hyg. 1978 Nov;27(6):1097–1107. doi: 10.4269/ajtmh.1978.27.1097. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES